HERC1 functions as a positive regulator of MSH2 protein stability; thus, reduction of MSH2 protein amount and chemoresistance are possibly achieved as a result of HERC1 deletion/inactivation in ALL cells. This evidence concerns the gene MSH2 and acute lymphoblastic leukemia.